avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gata5
|
ENSMUSG00000015627.5 | GATA binding protein 5 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Gata5 | mm10_v2_chr2_-_180334665_180334704 | 0.89 | 4.0e-13 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.0 | 39.1 | GO:0002215 | defense response to nematode(GO:0002215) |
10.7 | 32.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
9.3 | 37.2 | GO:0045575 | basophil activation(GO:0045575) |
8.7 | 69.8 | GO:0015671 | oxygen transport(GO:0015671) |
8.7 | 26.1 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
4.0 | 24.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
3.6 | 10.9 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
3.4 | 10.3 | GO:0002865 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) negative regulation of hypersensitivity(GO:0002884) |
3.0 | 20.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
2.7 | 27.2 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
2.3 | 13.6 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
2.2 | 6.7 | GO:0003127 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
1.9 | 7.7 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
1.9 | 33.7 | GO:0016075 | rRNA catabolic process(GO:0016075) |
1.8 | 5.3 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
1.8 | 5.3 | GO:1902567 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) astrocyte chemotaxis(GO:0035700) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) negative regulation of eosinophil activation(GO:1902567) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) regulation of astrocyte chemotaxis(GO:2000458) |
1.6 | 6.6 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
1.6 | 16.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.5 | 4.4 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
1.5 | 14.6 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
1.3 | 15.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.2 | 4.9 | GO:0061386 | closure of optic fissure(GO:0061386) |
1.0 | 5.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.0 | 1.0 | GO:0051595 | response to methylglyoxal(GO:0051595) |
1.0 | 4.9 | GO:0016068 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
0.7 | 17.2 | GO:0042730 | fibrinolysis(GO:0042730) |
0.7 | 2.0 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.6 | 10.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.6 | 12.6 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.6 | 5.5 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.6 | 20.4 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.6 | 3.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.5 | 5.4 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.5 | 21.4 | GO:0032094 | response to food(GO:0032094) |
0.5 | 5.9 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.4 | 6.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.4 | 6.0 | GO:0070269 | pyroptosis(GO:0070269) |
0.4 | 4.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.4 | 16.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.4 | 4.2 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.3 | 2.1 | GO:0035026 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) leading edge cell differentiation(GO:0035026) |
0.3 | 4.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 20.5 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.3 | 1.2 | GO:0034241 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.3 | 36.1 | GO:0007586 | digestion(GO:0007586) |
0.3 | 3.3 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.2 | 10.1 | GO:0048821 | erythrocyte development(GO:0048821) |
0.2 | 6.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 1.3 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 31.7 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.2 | 0.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 3.7 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.9 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 5.4 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.2 | 13.5 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 1.8 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 1.0 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.2 | 0.3 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 6.1 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 10.4 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 2.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.4 | GO:0046098 | purine nucleobase salvage(GO:0043096) guanine metabolic process(GO:0046098) hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 3.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 5.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 1.6 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 14.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 5.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 1.2 | GO:0098970 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
0.1 | 0.9 | GO:0035878 | nail development(GO:0035878) |
0.1 | 2.9 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 6.2 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 1.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 3.2 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 2.5 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.3 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.0 | 1.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 1.8 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.8 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 3.6 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 2.1 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 4.4 | GO:0008380 | RNA splicing(GO:0008380) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.7 | 93.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.2 | 15.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.1 | 3.4 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.9 | 6.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.7 | 17.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.7 | 4.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.7 | 3.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.5 | 2.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.4 | 12.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 1.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 14.4 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 1.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.3 | 1.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 4.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 3.1 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 4.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 3.2 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 14.3 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 2.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 1.6 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 1.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 2.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 16.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 14.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 25.2 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 6.7 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 5.0 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 29.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 3.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 1.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 1.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 5.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 16.4 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 6.8 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 23.0 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 6.1 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.0 | 1.7 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 46.0 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 2.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 7.9 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 7.0 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 34.3 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 12.6 | GO:0031410 | cytoplasmic vesicle(GO:0031410) |
0.0 | 10.6 | GO:0005730 | nucleolus(GO:0005730) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.9 | 29.7 | GO:0002113 | interleukin-33 binding(GO:0002113) |
9.4 | 37.7 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
7.6 | 45.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
5.2 | 26.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
5.0 | 10.1 | GO:0031720 | haptoglobin binding(GO:0031720) |
3.4 | 24.0 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
2.7 | 13.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
2.4 | 16.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.1 | 16.7 | GO:0004064 | arylesterase activity(GO:0004064) |
1.8 | 5.3 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
1.7 | 18.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.7 | 32.0 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
1.6 | 10.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.3 | 14.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.1 | 3.4 | GO:0001729 | ceramide kinase activity(GO:0001729) |
1.1 | 3.4 | GO:0070401 | NADP+ binding(GO:0070401) |
1.1 | 6.6 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
1.1 | 3.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
1.0 | 7.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.8 | 3.9 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.7 | 6.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.6 | 5.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 12.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.5 | 32.2 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.5 | 30.3 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.4 | 3.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 11.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.4 | 3.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.4 | 2.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 70.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 15.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 1.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.3 | 84.2 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.3 | 2.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 3.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 4.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 1.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 2.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 1.3 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.2 | 10.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 22.0 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 2.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 5.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 1.2 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.1 | 1.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 10.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 5.9 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 6.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 6.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 2.5 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.1 | 28.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.3 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.1 | 4.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 4.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 14.9 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.1 | 4.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 6.7 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 8.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 6.8 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 1.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 4.8 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 3.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 1.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 1.8 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 8.7 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 2.6 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 76.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.1 | 36.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.9 | 24.0 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.7 | 10.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.6 | 14.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 26.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 5.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 3.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 8.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 3.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 5.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 12.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 24.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 14.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 2.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 2.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 1.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 15.6 | REACTOME DEFENSINS | Genes involved in Defensins |
1.4 | 20.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.3 | 42.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.8 | 13.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.7 | 14.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.5 | 24.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 21.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.4 | 20.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 10.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 2.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 4.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 3.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 5.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 4.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 30.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 5.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 5.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 1.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 1.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 2.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |